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Abstract
Background: NANOG is a key player in pluripotency and its expression is restricted to pluripotent cells of the inner cell mass,
the epiblast and to primordial germ cells. Spermatogenesis is closely associated with pluripotency, because through this
process highly specialized sperm cells are produced that contribute to the formation of totipotent zygotes. Nevertheless, it
is unknown if NANOG plays a role in this process.
Methodology/Principal Findings: In the current study, NANOG expression was examined in testes of various mammals,
including mouse and human. Nanog mRNA and NANOG protein were detected by RT-PCR, immunohistochemistry, and
western blotting. Furthermore, eGFP expression was detected in the testis of a transgenic Nanog eGFP-reporter mouse.
Surprisingly, although NANOG expression has previously been associated with undifferentiated cells with stem cell
potential, expression in the testis was observed in pachytene spermatocytes and in the first steps of haploid germ cell
maturation (spermiogenesis). Weak expression in type A spermatogonia was also observed.
Conclusions: The findings of the current study strongly suggest a conserved role for NANOG in meiotic and post-meiotic
stages of male germ cell development.
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Introduction
NANOG, named after a mythical Celtic land of the ever young,
is a homeobox transcription factor and a key player in
pluripotency; i.e. the ability of a cell to differentiate into any fetal
or adult cell type [1,2]. NANOG is expressed in pluripotent cell
lines, including embryonic stem (ES) cells and embryonic germ
(EG) cells and loss of NANOG results in a tendency of ES cells to
differentiate [1–3]. On the other hand, mouse ES cells that
constitutively express Nanog are less sensitive to differentiation
signals and do not require LIF to maintain an ES cell identity [2].
Fusion of somatic cells with ES cells that express elevated levels of
NANOG facilitates reprogramming of the restricted somatic
genome to a pluripotent state [4].
In vivo expression of NANOG is restricted to cells of the inner
cell mass (ICM), the pluripotent epiblast, and primordial germ
cells (PGCs), all of which are sources for pluripotent cell lines
[1,2,5]. In mouse development, NANOG becomes detectable in
migrating PGCs of E7.75–E8.0 embryos. In gonadal germ cells of
E13.5 and E14.5 female embryos, NANOG is undetectable in cells
positive for the synaptonemal complex-specific protein SCP3. In
germ cells of E14.5–E16.5 male embryos, NANOG expression is
lost during the mitotic arrest [5].
The ICM cells of Nanog2/2 embryos fails to acquire pluripotency
and does not develop into pluripotent epiblast cells [1,6]. When put
into culture, explanted ICM cells differentiate entirely into extraem-
bryonic endoderm lineages [1]. Remarkably, however, Nanog2/2
ICM cells can participate in chimaeric embryonic development and
contribute to all three embryonic germ layers. This demonstrates that
in pluripotent cells NANOG is dispensable for the potential to
differentiate into all somatic tissues. However, in these chimaeras, the
Nanog2/2 cells that became committed to the primordial germ cell
lineage did not survive beyond E11.5, indicating that Nanog is
indispensable for the development of postmigratory germ cells [3].
Somatic cells that are induced to pluripotency by the
introduction of exogenous reprogramming factors do not require
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exogenous NANOG for this process [7]. However, Nanog2/2
neuronal stem cells can not be reprogrammed to pluripotency,
unless they carry a transgene that expresses NANOG [6]. It seems
that Nanog is dispensable for the initial dedifferentiation to occur,
but essential for the final stage of reprogramming to allow
pluripotency [6].
Male germ cells appear to be an important source of cells that
are directly linked to pluripotency. Teratocarcinomas, for
example, are malignant germ cell tumors that are composed of
pluripotent cells and differentiated progeny of numerous cell types
[8]. Moreover, a number of recent reports describe the derivation
of pluripotent cells from neonatal and adult mouse [9–13] and
human [14–16] testes. However, the immediate link between testis
and pluripotency is evidently spermatogenesis: the production of
sperm cells that can fertilize oocytes and thereby contribute to the
formation of completely new organisms.
Despite the evidence for the expression of Nanog in the testes of
several species [17–20] and obvious link between testis function
and pluripotency, little is known about the involvement of
NANOG in the process of spermatogenesis. In the current study
we describe NANOG expression in the testis and determine its
expression pattern in mammalian species ranging from mouse,
dog, and pig, to human. The dynamics of NANOG expression
throughout spermatogenesis was similar between species suggest-
ing a conserved role for NANOG in male meiosis and
spermiogenesis.
Results
We detected the presence of Nanog mRNA in mouse testes of
two different strains by reverse transcriptase-polymerase chain
reaction (RT-PCR) (Fig. 1A). Transcription from the locus of
Nanog in mouse testes was further confirmed by the detection of
testicular eGFP transcripts in transgenic Nanog eGFP-reporter mice
(TNG) [3] (Fig. 1B). Further investigation in other species revealed
NANOG expression in dog, pig, and human testes (Fig. 1C, D).
Importantly, rigorous negative controls demonstrated that PCR
products were not derived from genomic DNA.
Localization of NANOG protein expression was performed on
mouse testis sections using immunohistochemistry and expression
was detected in the nucleus of pachytene spermatocytes and round
spermatids (Fig. 2A–C). Weak staining for NANOG was also
detected in type A spermatogonia in all stages of the epithelial
cycle (e.g. Fig. 2A), but NANOG was not detected in intermediate
spermatogonia (data not shown). Control sections in which the
primary antibody solution was replaced by blocking solution did
not show any signal in the seminiferous tubules (Fig. 2D). Next, we
examined eGFP expression in testes sections of TNG mice.
Although fluorescent cells were not detected by microscopy or
FACS (data not shown) expression of eGFP was detected by
immunohistochemistry. The cell types expressing eGFP in the
testis of Nanog reporter mice corresponded to the cell types
expressing NANOG (Fig. 2E). As expected, eGFP staining was not
observed in testis sections of a non-transgenic mouse.
Categorization of the cell types that express NANOG in the
spermatogenic stages of the seminiferous epithelium [21] revealed
a distinctive temporal expression pattern. The expression dynam-
ics of NANOG in mouse testes at the various epithelial stages of
spermatogenesis are summarized in Figure 3A. NANOG was
detected in nuclei of pachytene spermatocytes from epithelial stage
IV onwards. Expression was maintained throughout meiosis and
NANOG was detected until spermiogenic step 10. Expression was
progressively lost in the course of elongation of spermatids.
We next analyzed the localization of NANOG expression in
dog testis. The expression pattern resembled the patterns
observed in the mouse testes and NANOG was mainly detected
in maturing gametes (Fig. 4). NANOG was specifically expressed
Figure 1. Expression of Nanog in testis of various mammalian species as determined by RT-PCR. (A) Expression of Nanog in mouse testis
of the Black 6 strain (BL/6) and the SV129 strain (SV129) (B) Expression of eGFP in testis of a TNG mouse; (C) Expression of NANOG in dog and pig
testes; (D) Expression of NANOG in human testis; in all RT-PCR experiments, amplicons were of the expected sizes (See also Table 2) and products
were identified by sequence analysis. Abbreviations: TNG= testis cDNA from Nanog eGFP reporter mouse; Cf= Canis familiaris, Ss= Sus scrofa, Hs=
Homo sapiens; + = cDNA synthesis reaction performed with reverse transcriptase, 2 = minus reverse transcriptase control.
doi:10.1371/journal.pone.0010987.g001
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in pachytene spermatocytes and round spermatids of dog testis
with a dynamic temporal expression pattern in the spermatogenic
stages of seminiferous tubules. At canine epithelial stage V, just
before spermatids initiate elongation [21], NANOG was
expressed in pachytene spermatocytes, but not in elongating
spermatids (Fig. 4A–C). The meiotic divisions in dogs occur at
epithelial stage VIII and metaphase configurations and newly
formed round spermatids were positive for NANOG at this stage.
Spermatids remained positive for NANOG up until stage V
(Fig. 4D–F). The expression dynamics of NANOG in dog testis at
the various epithelial stages of spermatogenesis are summarized
in Figure 3B, which illustrates that the observed expression
pattern for NANOG in dog testis corresponds well to that
observed in the mouse.
The presence of NANOG protein in dog testis was confirmed
by immunoblot analysis (Fig. 5). A distinctive band of approxi-
mately 40 kDa, which corresponds to the molecular weight of
NANOG, was observed in lysates from mES cells and dog testis.
Additional bands in both mES cell and dog testis lysates were
observed at approximately 80 kDa.
NANOG expression was also detected in maturing gametes in
adult porcine testis, as determined by immunofluorescence on
paraffin-embedded sections (Fig. 6). Expression was detected in
pachytene spermatocytes, as determined by the morphology of
their DNA (Fig. 6A–F). Protein expression of NANOG in porcine
testis was further confirmed by immunoblot analysis (Fig. 5).
Additional bands in both mES cell and pig testis lysates were
observed at approximately 80 kDa. NANOG protein expression
was also detected in human testes as determined by immunoflu-
orescence (Fig. 7). As in the other species examined, NANOG was
localized to differentiating male germ cells.
Discussion
NANOG is an essential factor for establishing pluripotency [6].
Recent studies have demonstrated that, in addition to cells of the
ICM, the epiblast, primordial germ cells, and cultured male germ
cells from mouse and human testes can give rise to pluripotent
stem cells [9–16]. In the current study, we examined the
expression of NANOG in male germ cells, since NANOG is
Figure 2. Expression of NANOG and eGFP in mouse testes sections as detected by immunohistochemistry. (A–C) Expression of NANOG
in mouse testis at different stages of spermatogenesis; Roman figures in seminiferous tubules represent the stage of the epithelial cycle; (D) Negative
control section from which the primary antibody was omitted in the staining procedure; (E) Expression of eGFP in testis sections of a Nanog eGFP
reporter; (F) eGFP staining on testis sections of a non-transgenic mouse, which served as a negative control for the staining in figures E.
Abbreviations: AS = type A spermatogonia, P = Pachytene spermatocyte, T = Spermatid, ET = elongating spermatids, S = Sertoli cell, * = non-specific
binding to interstitial cells. Sections displayed in panels A–D were fixed in Bouins fixative; sections in panels E and F were fixed in formalin. Formalin
fixation interfered with immunostaining of the seminiferous tubules.
doi:10.1371/journal.pone.0010987.g002
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expressed in other cell types from which pluripotent cell lines have
been established [1,2,5,18].
Nanog transcripts and protein were detected in testes of mouse,
dog, pig, and human. Furthermore, eGFP mRNA and protein
were detected in the testis of Nanog reporter mice, which is strong
evidence that the Nanog gene is transcribed in mouse testis.
Multiple antibodies of different origins showed specific and
comparable staining for NANOG in different species. Moreover,
the observed expression in type A spermatogonia, spermatocytes,
and round spermatids corresponds well to that described in
previous studies of human [19] and porcine testes [20].
Importantly, the antibody that was used by Ezeh et al. (2005)
was raised against a different epitope compared to the various
antibodies that were used in our study. Consequently, it is unlikely
that the signals described here originate from non-specific binding.
In some previous studies, Nanog expression was not detected in
mouse testis, even though expression was observed in cells of the
ICM, the epiblast, and in primordial germ cells [1,5]. Another
study has detected NANOG in human fetal gonocytes, testicular
carcinoma in situ and germ cell tumours, but not in normal adult
testis [22]. Similarly, NANOG expression has also been detected
in fetal gonocytes of the marmoset, but not in adult testis [23].
This probably indicates that the expression levels described here
are relatively weak in differentiating male germ cells. Indicative of
this low expression is the lack of detection of fluorescent cells by
microscopy or FACS (data not shown) in TNG mouse testis.
Nevertheless, eGFP could clearly detected by immunohistochem-
istry in TNG mouse testis, but not in the testis of non-transgenic
mice. The sensitivity of the various approaches in the current study
could have been decisive for the successful detection of NANOG
in testes.
In transgenic mice that can express a short hairpin RNA against
Nanog after tamoxifen exposure, conditional knockdown of Nanog in
migratory PGCs induces apoptotic cell death and results in a
Figure 3. Models for the dynamic expression of NANOG in the epithelial cycle of murine (top) and canine (bottom)
spermatogenesis. Each column represents the combination of different cell types that are present in seminiferous tubules at that specific
stage. Roman figures = stage of the epithelial cycle, In = intermediate spermatogonia, B = type B spermatogonia, Pl = pre-leptotene stage, L =
leptotene stage, Z = zygotene stage, P = pachytene stage, D = diplotene stage, 2nd = generation of secondary spermatocytes, 1–16 = steps in
spermiogenesis. Cell types that express NANOG are outlined in red and cell types that do not express NANOG have black and grey symbols.
doi:10.1371/journal.pone.0010987.g003
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reduction of the number of PGCs in E12.5 embryos [24]. The
authors of this study also describe that embryonic Cre-recombi-
nase mediated down regulation of Nanog resulted in tubules with
disrupted spermatogenesis in the adult testes, which contained
scattered TRA98-positive spermatogonia in the otherwise empty
tubules. The authors interpreted this phenotype as developmental
retardation of the seminiferous tubule probably caused by the
embryonic loss of Nanog-negative germ cells [24]. However, the
observed phenotype could also indicate a role for Nanog in
spermatogenesis. The lack of meiotic and post meiotic stages
correlates with our data on the onset of NANOG expression in
pachytene spermatocytes.
Figure 4. Expression of NANOG in dog testis as determined by immunofluorescence. (A–F) NANOG expression in differentiating male
germ cells. Roman figures in panels represent the stage of the canine epithelial cycle (G–I) high magnification image of section in which the primary
antibody was replaced by blocking solution, to control for non-specific binding of the secondary antibody; (J–L) image of testis section that was
incubated with a rabbit IgG isotype control, to control for non-specific binding of the primary antibody.
doi:10.1371/journal.pone.0010987.g004
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In the course of germ cell development, male germ cells
undergo critical epigenetic changes intended for successful
progression through meiosis, meiotic sex chromosome inactiva-
tion, post-meiotic sex-chromosome repression, and chromatin
remodeling [25]. The fundamental role of histone and DNA
methyltransferases and other epigenetic modifiers in male meiosis
is exemplified by various knockout studies that result in arrest and/
or apoptosis of early to late pachytene spermatocytes [25,26].
NANOG could be involved in these epigenetic events in
spermatogenesis. For example, NANOG is known to interact
with repression complexes that contain active histone deacetylases
[27,28]. Inhibition of histone deacetylase-1 results in male
infertility through apoptosis in spermatogonia and spermatocytes
[29,30].
In conclusion, in the present study we demonstrated that Nanog
is expressed in mammalian differentiating male germ cells. In
mouse testis, weak expression in type A spermatogonia was also
observed. The reported meiotic and post-meiotic association of
NANOG in male germ line cells suggests a role for NANOG as
epigenetic modifier in spermatogenic reprogramming.
Materials and Methods
Ethics statement
After institutional approval, mouse testes were obtained from
fertile males that were housed at the Utrecht University Central
Animal Facilities and the MRC Center Development in Stem Cell
Biology, Institute for Stem Cell Research, School of Biological
Sciences, University of Edinburgh. Because we made use of post-
mortem surplus material from animals that were used for other
experiments, ethical approval to use this material was not
necessary. Surplus canine testicles were obtained from healthy
client-owned dogs that underwent routine elective gonadectomy,
performed by surgeons of the Department of Clinical Sciences of
Companion Animals, Faculty of Veterinary Medicine, Utrecht,
The Netherlands. Adult pig testes were collected at a local
slaughterhouse. Anonym human testis samples for RNA isolation
were obtained at the Center for Reproductive Medicine,
Academic Medical Center, Amsterdam, from 2 patients undergo-
ing bilateral castration as part of prostate cancer treatment.
Patients were asked to donate this spare material for research and
gave oral consent. Written consent was not considered necessary
because the material would otherwise be discarded and because
the consent of the patient was documented in their medical files.
Ethics committee approval was not obtained, because according to
Dutch law this is not necessary when anonym tissue samples are
used. None of these men had previously received chemotherapy or
radiotherapy, and the morphology of the testes showed normal
spermatogenesis in all cases. Anonymized, sections embedded in
paraffin of post-mortem human testes were obtained from the
Biobank at the Department of Pathology of the University Medical
Center in Utrecht. Approval to use this material for the current
study was obtained from the scientific committee of the
Department of Pathology of the University Medical Center in
Utrecht (PA code RP 2007-34). There were no indications that this
material was derived from infertile men or men suffering from
testicular diseases as determined by testis morphology.
RNA extraction, reverse transcription, and PCR
From human testes, mRNA was extracted using the MagNA
Pure LC (Roche, Basel, Switzerland) according to the manufac-
turer’s protocol. For cDNA synthesis 0.03 mg of mRNA of human
testis tissue was used in a reverse transcriptase reaction with
random primers and M-MLV reverse transcriptase (Invitrogen,
Groningen, The Netherlands). For mouse, dog, and pig, total
RNA was isolated from 50–100 mg testis sections with Trizol
(Invitrogen), according to the manufacturer’s protocol with an
additional purification step immediately following phase separa-
tion. In this extra step, one volume of phenol:chloroform:isoamyl
alcohol (Fluka, Sigma-Aldrich, Zwijndrecht, The Netherlands) was
added to the aqueous phase and samples were mixed, incubated at
room temperature (RT) for 5 min, and centrifuged. Subsequently,
samples were incubated at RT for an additional 5 min, after which
the aqueous phase was transferred to a new tube and put on ice.
From here, the Trizol RNA isolation protocol was resumed, from
the RNA precipitation step onwards. The presence of Nanog
pseudogenes requires reliable negative controls in RT-PCR
experiments [31]. Therefore, RNA was treated with 2 ml DNAse
(2,75 Kunitz units/ml; Qiagen, Venlo, The Netherlands) for 20min
at 37uC, after which incubation at 65uC for 10 min was performed
to inactivate the enzyme. Next, RNA was reverse-transcribed to
first strand cDNA with Superscript III (Invitrogen) according to
the company’s instructions. Random primers were used and for
each sample an equivalent mixture was prepared, from which
Superscript III was omitted, to control for genomic DNA
contamination. Reverse transcribed cDNA samples were stored
at 220uC before they were used in a polymerase chain reaction.
Species-specific primers for Nanog were designed with Beacon
Designer 4 (PREMIER Biosoft International, Palo Alto, CA, USA;
(Table 1).
Complementary DNA amplification was performed with
HotStarTaq (Qiagen) according to the manufacturer’s protocol.
The reaction mixture contained 2 nM MgCl2 and 0.5 mM of each
primer. To 24 ml of mixture, 1 ml of sample was added, after which
the PCR was carried out in a MyCycler (Bio-Rad). Each PCR
started with a 15-min dwell at 94uC, followed by 40 cycles with 3
steps/cycle; 30 sec melting of double strands at 94uC, 30 sec
annealing at the primer specific annealing temperature (Table 1),
and finally 30 sec elongation at 72uC. For each sample, RT
negative controls were used in all reactions to prevent contami-
nation with genomic DNA. The amplicons (10 ml) were electro-
phoresed in 1% agarose gels and sequence analysis was used to
confirm the amplification of Nanog transcripts in all species.
Immunoblot analysis
Total protein was extracted with lysis buffer containing 25 mM
2-(N-morpholino) ethanesulfonic acid monohydrate (Sigma-
Figure 5. Immunoblot analysis. Composite image of immunoblot
results for NANOG on lysates of mouse ES cells and dog and pig testes.
On the right is a Benchmark protein ladder (Invitrogen) and the
indicated molecular weights for each band. Abbreviations: mES=
mouse embryonic stem cells, Cf= Canis familiaris, Ss= Sus scrofa.
doi:10.1371/journal.pone.0010987.g005
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Aldritch), 150 mM NaCl, 1 mM EGTA, protease inhibitors
(Roche), and 1% Triton X-100. The amount of protein was
determined by a DC protein assay (Bio-Rad) and 5–20 mg of total
protein, was boiled for 5 min in Laemmli buffer (Bio-Rad) with
0.5 M b-mercaptoethanol and separated by electrophoresis on a
12% Tris–HCl PAGE gel. To determine protein sizes, a
benchmark pre-stained protein ladder was run in each gel. After
electrophoresis, proteins were transferred to a Trans-Blot
nitrocellulose transfer membrane (Bio-Rad). Subsequently, mem-
branes were blocked overnight at 4uC with 5% Blotting Grade
Blocker non-fat dry milk (Bio-Rad), in PBST and incubated with
1 mg/ml rabbit polyclonal anti-mouse NANOG (Chemicon) in 5%
Figure 6. Expression of NANOG in pig testis as determined by immunofluorescence. (A–C) NANOG expression in differentiating male germ
cells; (D–F) high magnification image of NANOG expression in pachytene spermatocytes; (G–I) image of section in which the primary antibody was
replaced by blocking solution, to control for non-specific binding of the secondary antibody; (J–K) representative high magnification image of testis
section that was incubated with a rabbit IgG isotype control, to control for non-specific binding of the primary antibody. Dashed lines in panels A–C
and G–I mark the boundaries of the tubules.
doi:10.1371/journal.pone.0010987.g006
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non-fat dry milk for 1 hr at room temperature. Membranes were
washed in PBST, and subsequently incubated for 1 hr at RT in a
horseradish peroxidase-conjugated goat anti-rabbit IgG (Pierce,
Rockford, USA) secondary antibody solution diluted 1:5000 in 5%
non-fat dry milk. Specific binding of the antibodies was visualized
using SuperSignal West Dura Extended Duration Substrate
(Pierce, Rockford, IL) after which the blots were exposed to film
(Kodak). The primary antibody is known to bind non-specifically
to a 55 kDa protein and therefore, bands detected at that height
were considered non-specific.
Immunohistochemistry, Immunofluorescence, and
Confocal Laser Scanning Microscopy
After collection, testes were fixed overnight (o/n) in 4% PFA or
Bouins fixative and embedded in paraffin using standard
procedures the following day. Sections were cut at 5–7 mm and
mounted on superfrost plus slides (Menzel, Braunschweig,
Germany), which were dried o/n at 37uC and stored at 4uC until
further use. For IHC with the NANOG antibody (Table 2) on
mouse sections, endogenous peroxidases were blocked with 1.5%
H2O2 (Merck) in 40 mM citric acid and 120 mM Na2HPO4 for
15 min at RT. After antigen retrieval with 10 mM EDTA buffer
(20 min, pH 9), non-specific binding sites were blocked with 1%
bovine serum albumin in PBS for 30 min at RT. After blocking,
sections were incubated with rabbit anti-nanog (Bethyl, Mon-
tgomery, USA) in blocking solution overnight at 4uC. Slides were
incubated with a Powervision poly-HRP-anti-rabbit conjugated
secondary antibody (ImmunoVision Technologies) for 1 hr at RT.
Subsequently, sections were incubated in Fast 3,39-diaminobenze-
dine (Sigma-Aldrich) and counterstained with heamatoxylin.
Slides were mounted with Pertex (Klinipath, Duiven, The
Netherlands).
For immunohistochemistry with the GFP antibody (Table 2),
PFA fixed mouse sections were deparaffinized after which
endogenous peroxidases were blocked with methanol/0.3%
H2O2. Next, antigen retrieval was performed by boiling the slides
for 10 min in EDTA buffer (1 mM, pH 9). Endogenous biotin was
blocked by incubation of the sections with avidin and biotin,
respectively. Subsequently, non-specific binding was blocked with
10% normal goat serum in 0.05% Tween in PBS (PBST) for
30 min at RT after which the blocking solution was replaced by
primary antibody solution diluted in 2% normal goat serum (NGS)
in PBST (60 min at RT). Sections were then incubated in
biotinylated goat anti-mouse IgGs (1:100; Dako, Heverlee,
Belgium) in 2% NGS in PBST for 30 min at RT. After 20 min
incubation with horseradish peroxidase (HRP)-conjugated strep-
tavidin (DAKO) in 2% NGS in PBST, slides were incubated
in AEC solution (Sigma-Aldrich) and counter stained with
hemaetoxylin.
For immunofluorescence, slides were deparaffinized in xylene
and subjected to antigen retrieval by boiling the slides for 10 min
in citrate buffer (pH 2 or pH 6). For canine testis sections,
Figure 7. Expression of NANOG in human testis as determined by immunofluorescence in paraffin-embedded sections. (A–C) NANOG
expression in differentiating male germ cells; dashed lines mark the boundaries of tubules.
doi:10.1371/journal.pone.0010987.g007
Table 1. Primers used for RT-PCR and sequence analysis.
Gene Sequence origin Primers Ta (uC) Amplicon size (bp) Application
Mouse
Nanog
NM_028016 F: 59-AGATGCGGACTGTGTTCTC-39
R: 59-TGCGTTCACCAGATAGCC-39
58 281 PCR/sequence
Canine
NANOG
XM_543828 F: 59-CCGTCTCTCCTCTTCCTTC-39
R: 59-CACTGTTGCTCTCCTTTGG-39
54,3 348 PCR/sequence
Porcine
NANOG
NM_001129971 F: 59-CTCTCCTCTTCCTTCCTC-39
R: 59-ATCACACTGTTGCTATTCC-39
58 345 PCR/sequence
Human
NANOG
NM_024865 F: 59-CCTCCAGCAGATGCAAGAACTC-39
R: 59-GTAAAGGCTGGGGTAGGTAGGTG-39
58 172 PCR/sequence
eGFP EU541500 F1: 59-CTGGTCGAGCTGGACGGCGACG-39
R1: 59-CACGAACTCCAGCAGGACCATG-39
59 630 PCR/sequence
F = forward primer, R = reverse primer. Ta = annealing temperature used in PCR reaction.
doi:10.1371/journal.pone.0010987.t001
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additional antigen retrieval was performed by putting the slides in
methanol for 10 sec. Following antigen retrieval, slides were
permeabilized in TBS containing 0.05% Tween (TBST) and
Triton X-100 (0.1%). Permeabilized slides were blocked for 1 hr
in TBST containing 0.5% BSA (Sigma-Aldrich) followed by o/n
incubation with the primary antibody (Table 2) in blocking
solution at 4uC. The following day, slides were incubated in the
secondary antibody in blocking solution for 1 h at 4uC, after which
the slides were counterstained with TOPRO-3 (Invitrogen) and
mounted in Vectashield. DNA could not be visualized after
antigen retrieval at pH 2.
Fluorescent images were analyzed at the Center for Cell
Imaging at the Faculty of Veterinary Medicine in Utrecht.
Fluorescent signals were visualized using a Confocal Laser
Scanning Microscope (Bio-Rad) and on an epifluorescence
microscope from which pictures were captured with a CCD
camera. Within each session, identical settings were used to image
NANOG stains and negative controls. For post-capture analysis,
only brightness and contrast were used to enhance signals and
negative control images were treated in an equal manner.
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